TP53 and hydrops fetalis: Thus, future cardiac-restricted and lineage-specific transgenic approaches will be required to determine which specific p53 targets are temporally dysregulated, as well as where and how juvenile p53 pathway hyperactivation prevents HF that is eventually observed in adult mutants.